Graves' disease is the leading cause of an overactive thyroid, known as hyperthyroidism. This condition occurs when the immune system mistakenly attacks the thyroid gland, causing it to produce excessive amounts of thyroid hormones. The disorder bears the name of Robert James Graves, an Irish doctor who first described it in the 1830s. Beta-blockers, Anti-thyroid medications, Radioactive iodine treatments, and Surgery are some of the treatment options for Graves' disease.
The company we are profiling today is Immunovant Inc. (IMVT), which is developing a drug for Graves' disease.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.